Follow the people · Insider
Amy Simon
Amy Simon files insider transactions with the SEC as a chief medical officer of Beam Therapeutics (BEAM). We hold 3 disclosed purchases and sales filed since 31 March 2023, 2 of them in the last 90 days.
- Files forBEAM
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure29 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 March 2023 — 27 July 2026Chief Medical Officer · Beam Therapeutics (BEAM)26 Form 4 lines · source: SEC Form 4
Everything they disclosed
26 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 16,667 shares of Beam TherapeuticsSEC Form 429 July 2026Common Stock · traded 27 July 2026 · filed 29 July 2026
- ▼ sold on the open market 373 shares of Beam TherapeuticsSEC Form 42 July 2026Common Stock · traded 30 June 2026 · filed 2 July 2026
- ▼ sold on the open market 6,700 shares of Beam TherapeuticsSEC Form 46 April 2026Common Stock · traded 1 April 2026 · filed 6 April 2026
- was granted 31,750 shares of Beam TherapeuticsSEC Form 42 April 2026Common Stock · traded 31 March 2026 · filed 2 April 2026
- was granted 88,500 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 31 January 2026 · filed 2 February 2026
- was granted 88,500 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 31 January 2026 · filed 2 February 2026
- was granted 12,500 shares of Beam TherapeuticsSEC Form 45 January 2026Common Stock · traded 31 December 2025 · filed 5 January 2026
- was granted 12,500 shares of Beam TherapeuticsSEC Form 45 January 2026Common Stock · traded 31 December 2025 · filed 5 January 2026
- ▼ sold on the open market 374 shares of Beam TherapeuticsSEC Form 43 July 2025Common Stock · traded 1 July 2025 · filed 3 July 2025
- ▼ sold on the open market 876 shares of Beam TherapeuticsSEC Form 43 July 2025Common Stock · traded 3 July 2025 · filed 3 July 2025
- ▼ sold on the open market 9,566 shares of Beam TherapeuticsSEC Form 43 April 2025Common Stock · traded 1 April 2025 · filed 3 April 2025
- ▼ sold on the open market 20,997 shares of Beam TherapeuticsSEC Form 43 April 2025Common Stock · traded 2 April 2025 · filed 3 April 2025
- was granted 27,500 shares of Beam TherapeuticsSEC Form 42 April 2025Common Stock · traded 31 March 2025 · filed 2 April 2025
- was granted 55,000 shares of Beam Therapeutics (a derivative holding)SEC Form 43 February 2025Stock Option (Right to Buy) · traded 31 January 2025 · filed 3 February 2025
- ▼ sold on the open market 502 shares of Beam TherapeuticsSEC Form 43 July 2024Common Stock · traded 1 July 2024 · filed 3 July 2024
- ▼ sold on the open market 748 shares of Beam TherapeuticsSEC Form 43 July 2024Common Stock · traded 2 July 2024 · filed 3 July 2024
- ▼ sold on the open market 7,157 shares of Beam TherapeuticsSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 16,530 shares of Beam TherapeuticsSEC Form 43 April 2024Common Stock · traded 2 April 2024 · filed 3 April 2024
- was granted 27,500 shares of Beam TherapeuticsSEC Form 42 April 2024Common Stock · traded 31 March 2024 · filed 2 April 2024
- was granted 55,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2024Stock Option (Right to Buy) · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 3,448 shares of Beam TherapeuticsSEC Form 41 November 2023Common Stock · traded 30 October 2023 · filed 1 November 2023
- ▼ sold on the open market 391 shares of Beam TherapeuticsSEC Form 49 August 2023Common Stock · traded 10 July 2023 · filed 9 August 2023
- ▼ sold on the open market 4,445 shares of Beam TherapeuticsSEC Form 45 April 2023Common Stock · traded 3 April 2023 · filed 5 April 2023
- ▼ sold on the open market 10,493 shares of Beam TherapeuticsSEC Form 45 April 2023Common Stock · traded 4 April 2023 · filed 5 April 2023
- ▼ sold on the open market 1,161 shares of Beam TherapeuticsSEC Form 45 April 2023Common Stock · traded 4 April 2023 · filed 5 April 2023
- was granted 20,000 shares of Beam TherapeuticsSEC Form 431 March 2023Common Stock · traded 31 March 2023 · filed 31 March 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.